Illumina Inc. said its Illumina Laboratory Services unit will provide clinical whole-genome sequencing and interpretation services to the new Diagnostic Lab at the Florida Institute for Pediatric Rare Diseases at Florida State University College of Medicine. The collaboration is intended to help the lab rapidly launch clinical rare-disease genome testing and improve diagnostic outcomes for pediatric patients.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Illumina Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202602270915PR_NEWS_USPR_____LA97456) on February 27, 2026, and is solely responsible for the information contained therein.